Developing a vaccine against HIV is still our best hope for containing the AIDS pandemic, says Danilo Casimiro, Merck's director of
basic vaccine research.
Not exact matches
Support for translational
research has helped with the development of new drugs, diagnostics and
vaccines, Hotez says, but funding for
basic research has lagged behind.
Notably, the
basic skills needed for
vaccine research are taught in most universities: immunology, molecular biology, protein purification and analysis, epidemiology, biostatistics, biochemical engineering.
Scientists contacted by Nature say that
basic research on such mutated strains may eventually yield insight relevant to developing pandemic countermeasures such as drugs and
vaccines.
Robert Garry, virologist engaged in envelope - protein
research that may lead to a SARS
vaccine, Tulane University School of Medicine, New Orleans: We've learned that it's good to support
basic scientific
research.
«The discovery of this new antibiotic was an unexpected result of
basic research on HIV proteins,» said senior author Ronald Montelaro, Ph.D., professor and co-director of Pitt's Center for Vaccine Researc
research on HIV proteins,» said senior author Ronald Montelaro, Ph.D., professor and co-director of Pitt's Center for
Vaccine ResearchResearch (CVR).
Developing - country
research is producing world - class results: a meningitis
vaccine in Cuba, malaria treatment in Thailand, a $ 300
basic computer in Brazil.
As VRC Director, Dr. Mascola provides scientific leadership to the
basic, clinical, and translational
research activities of the VRC; develops
vaccine research programs to meet public health needs; allocates VRC resources; and develops policies for the execution of multi-disciplinary
research.
«
Research focused on
basic B cell biology is the foundation for the development of an HIV
vaccine designed to drive the B cell arm of the immune response.»
Tags: Acute Myeloid Leukemia, Andrew Hsieh,
Basic Sciences, Clinical
Research, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational research, Vaccine development - Viral
Research, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational
research, Vaccine development - Viral
research,
Vaccine development - Viral cancers
The mission of the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM) is to improve human health by conducting
basic and translational
research that leads to the development of effective diagnostic biomarkers,
vaccines, antivirals and therapeutics for emerging, re-emerging, neglected or rare infectious diseases.
To address this growing problem, NIAID is funding and conducting
research on many aspects of antimicrobial (drug) resistance, including
basic research on how microbes develop resistance, development of new and faster diagnostics, and clinical trials designed to find new
vaccines and treatments effective against drug - resistant microbes.
Within the fields of microbiology and immunology, neurologic diseases, neuropharmacology, behavioral, cognitive and developmental neuroscience, and psychiatric disorders, the center's
research programs are seeking ways to: develop
vaccines for infectious and noninfectious diseases; understand the
basic neurobiology and genetics of social behavior and develop new treatment strategies for improving social functioning in social disorders such as autism; interpret brain activity through imaging; increase understanding of progressive illnesses such as Alzheimer's and Parkinson's diseases; unlock the secrets of memory; treat drug addiction; determine how the interaction between genetics and society shape who we are; and advance knowledge about the evolutionary links between biology and behavior.
The potential benefits of primate
research include an improved understanding of cancer, infectious diseases, neurological disorders, spinal cord injuries,
basic biological and behavioral processes, and the development of new medicines,
vaccines, devices and other treatments, according to scientific researchers.
Continuing its rich history of discoveries and biomedical breakthroughs, Wistar today is an international leader in
basic biomedical
research in cancer and infectious diseases, with a focus on discoveries leading to the development of novel therapies and
vaccines.
Their purpose is to facilitate the preclinical and clinical
research needed to translate the ideas generated through
basic research into safe and effective drugs,
vaccines, and diagnostics to control and prevent allergic, immunologic, or transplantation - related diseases and conditions.